The effect of tocilizumab, anakinra and prednisolone on antibody response to SARS-CoV-2 in patients with COVID-19: A prospective cohort study with multivariate analysis of factors affecting the antibody response

Creative Commons License

Başaran S., Şimşek-Yavuz S., Meşe S., Çağatay A., Medetalibeyoğlu A., Öncül O., ...Daha Fazla

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, cilt.105, ss.756-762, 2021 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 105
  • Basım Tarihi: 2021
  • Doi Numarası: 10.1016/j.ijid.2021.03.031
  • Dergi Adı: INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database, Directory of Open Access Journals
  • Sayfa Sayıları: ss.756-762
  • Anahtar Kelimeler: Tocilizumab, Anakinra, Prednisolone, SARS-CoV-2, Antibody, CHEST CT, VACCINE, IMMUNE
  • İstanbul Üniversitesi Adresli: Evet

Özet

Objectives: Disease severity, previous medications and immunosuppressive agents could affect the antibody response against SARS-CoV-2. This study aimed to analyze variables affecting the humoral response to SARS-CoV-2.